In type 2 diabetes patients with overt nephropathy, lispro insulin prevents glomerular hyperfiltration and reduces the renal effects of meal-associated hyperglycemia by mechanisms possibly related to insulin-like growth factor 1 (IGF-1) antagonism 56. This evidence concerns the gene INS and Hyperglycemia.